U.S. Markets closed

Evogene Ltd. (EVGN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
6.13-0.11 (-1.76%)
At close: 4:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close6.24
Open6.17
Bid6.13 x 900
Ask6.13 x 1100
Day's Range5.96 - 6.21
52 Week Range0.75 - 6.94
Volume958,942
Avg. Volume1,595,883
Market Cap228.46M
Beta (5Y Monthly)0.55
PE Ratio (TTM)N/A
EPS (TTM)-0.82
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est9.00
  • Biomica Announces Participation at the Crohn's & Colitis Congress® January 21-24, 2021 (Virtual Conference)
    PR Newswire

    Biomica Announces Participation at the Crohn's & Colitis Congress® January 21-24, 2021 (Virtual Conference)

    Biomica Ltd., an emerging biopharmaceutical company developing innovative microbiome-based therapeutics, and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN.TA), today announced it will be featured as a presenting company at the Crohn's & Colitis Congress® to be held from today January 21-24, 2021.

  • Biomica Announces Participation at the 5th Microbiome Movement Drug Development Europe Conference on January 28-29, 2021 (Virtual Conference)
    PR Newswire

    Biomica Announces Participation at the 5th Microbiome Movement Drug Development Europe Conference on January 28-29, 2021 (Virtual Conference)

    Biomica Ltd., an emerging biopharmaceutical company developing innovative microbiome-based therapeutics, and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN.TA), today announced it will be featured as a presenting company at the Microbiome Movement Drug Development Europe Conference. The conference is being held on January 28-29, 2021, virtually.

  • Shark Bites: A Computational Predictive Biology Play
    TheStreet.com

    Shark Bites: A Computational Predictive Biology Play

    Computation Predictive Biology (CPB) is defined as "the development and application of data-analytical and theoretical methods, mathematical modeling and computational simulation techniques to the study of biological, ecological, behavioral, and social systems." EVGN believes that its CPB platform gives it a competitive edge that increases efficacy, reduces toxicity, cuts costs of development, and saves time. The key areas of development are microbiome therapeutics, herbicides, pesticides, and medical cannabis.